Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis

The clinical therapeutics of cervical cancer is limited due to the drug resistance and metastasis of tumor. As a novel target for antitumor therapy, ferroptosis is deemed to be more susceptible for those cancer cells with resistance to apoptosis and chemotherapy. Dihydroartemisinin (DHA), the primar...

Full description

Bibliographic Details
Main Authors: Hanqiang Shi, Lie Xiong, Guang Yan, Shuqin Du, Jie Liu, Yanbo Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1156062/full
_version_ 1797855190817177600
author Hanqiang Shi
Hanqiang Shi
Lie Xiong
Lie Xiong
Guang Yan
Shuqin Du
Shuqin Du
Jie Liu
Yanbo Shi
Yanbo Shi
author_facet Hanqiang Shi
Hanqiang Shi
Lie Xiong
Lie Xiong
Guang Yan
Shuqin Du
Shuqin Du
Jie Liu
Yanbo Shi
Yanbo Shi
author_sort Hanqiang Shi
collection DOAJ
description The clinical therapeutics of cervical cancer is limited due to the drug resistance and metastasis of tumor. As a novel target for antitumor therapy, ferroptosis is deemed to be more susceptible for those cancer cells with resistance to apoptosis and chemotherapy. Dihydroartemisinin (DHA), the primary active metabolites of artemisinin and its derivatives, has exhibited a variety of anticancer properties with low toxicity. However, the role of DHA and ferroptosis in cervical cancer remained unclear. Here, we showed that DHA could time-dependently and dose-dependently inhibit the proliferation of cervical cancer cells, which could be alleviated by the inhibitors of ferroptosis rather than apoptosis. Further investigation confirmed that DHA treatment initiated ferroptosis, as evidenced by the accumulation of reactive oxygen species (ROS), malondialdehyde (MDA) and liquid peroxidation (LPO) levels and simultaneously depletion of glutathione peroxidase 4 (GPX4) and glutathione (GSH). Moreover, nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy was also induced by DHA leading to subsequent increases of intracellular labile iron pool (LIP), exacerbated the Fenton reaction resulting in excessive ROS production, and enhanced cervical cancer ferroptosis. Among them, we unexpectedly found that heme oxygenase-1 (HO-1) played an antioxidant role in DHA-induced cell death. In addition, the results of synergy analysis showed that the combination of DHA and doxorubicin (DOX) emerged a highly synergistic lethal effect for cervical cancer cells, which was related also to ferroptosis. Overall, our data revealed the molecular mechanisms that DHA triggered ferritinophagy-dependent ferroptosis and sensitized to DOX in cervical cancer, which may provide novel avenues for future therapy development.
first_indexed 2024-04-09T20:19:43Z
format Article
id doaj.art-53484792c2a84cc4a238fcba8685bc87
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-09T20:19:43Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-53484792c2a84cc4a238fcba8685bc872023-03-31T06:36:00ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-03-011010.3389/fmolb.2023.11560621156062Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosisHanqiang Shi0Hanqiang Shi1Lie Xiong2Lie Xiong3Guang Yan4Shuqin Du5Shuqin Du6Jie Liu7Yanbo Shi8Yanbo Shi9Central Laboratory of Molecular Medicine Research Center, Jiaxing Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jiaxing, ChinaJiaxing Key Laboratory of Diabetic Angiopathy Research, Jiaxing, ChinaCentral Laboratory of Molecular Medicine Research Center, Jiaxing Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jiaxing, ChinaJiaxing Key Laboratory of Diabetic Angiopathy Research, Jiaxing, ChinaDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaCentral Laboratory of Molecular Medicine Research Center, Jiaxing Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jiaxing, ChinaSchool of Pharmacy, Zhejiang University of Technology, Hangzhou, ChinaOncology Department, Jiaxing Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jiaxing, ChinaCentral Laboratory of Molecular Medicine Research Center, Jiaxing Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Jiaxing, ChinaJiaxing Key Laboratory of Diabetic Angiopathy Research, Jiaxing, ChinaThe clinical therapeutics of cervical cancer is limited due to the drug resistance and metastasis of tumor. As a novel target for antitumor therapy, ferroptosis is deemed to be more susceptible for those cancer cells with resistance to apoptosis and chemotherapy. Dihydroartemisinin (DHA), the primary active metabolites of artemisinin and its derivatives, has exhibited a variety of anticancer properties with low toxicity. However, the role of DHA and ferroptosis in cervical cancer remained unclear. Here, we showed that DHA could time-dependently and dose-dependently inhibit the proliferation of cervical cancer cells, which could be alleviated by the inhibitors of ferroptosis rather than apoptosis. Further investigation confirmed that DHA treatment initiated ferroptosis, as evidenced by the accumulation of reactive oxygen species (ROS), malondialdehyde (MDA) and liquid peroxidation (LPO) levels and simultaneously depletion of glutathione peroxidase 4 (GPX4) and glutathione (GSH). Moreover, nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy was also induced by DHA leading to subsequent increases of intracellular labile iron pool (LIP), exacerbated the Fenton reaction resulting in excessive ROS production, and enhanced cervical cancer ferroptosis. Among them, we unexpectedly found that heme oxygenase-1 (HO-1) played an antioxidant role in DHA-induced cell death. In addition, the results of synergy analysis showed that the combination of DHA and doxorubicin (DOX) emerged a highly synergistic lethal effect for cervical cancer cells, which was related also to ferroptosis. Overall, our data revealed the molecular mechanisms that DHA triggered ferritinophagy-dependent ferroptosis and sensitized to DOX in cervical cancer, which may provide novel avenues for future therapy development.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1156062/fullcervical cancerdihydroartemisininferroptosisferritinophagyheme oxygenase-1doxorubicin
spellingShingle Hanqiang Shi
Hanqiang Shi
Lie Xiong
Lie Xiong
Guang Yan
Shuqin Du
Shuqin Du
Jie Liu
Yanbo Shi
Yanbo Shi
Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
Frontiers in Molecular Biosciences
cervical cancer
dihydroartemisinin
ferroptosis
ferritinophagy
heme oxygenase-1
doxorubicin
title Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
title_full Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
title_fullStr Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
title_full_unstemmed Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
title_short Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
title_sort susceptibility of cervical cancer to dihydroartemisinin induced ferritinophagy dependent ferroptosis
topic cervical cancer
dihydroartemisinin
ferroptosis
ferritinophagy
heme oxygenase-1
doxorubicin
url https://www.frontiersin.org/articles/10.3389/fmolb.2023.1156062/full
work_keys_str_mv AT hanqiangshi susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT hanqiangshi susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT liexiong susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT liexiong susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT guangyan susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT shuqindu susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT shuqindu susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT jieliu susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT yanboshi susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis
AT yanboshi susceptibilityofcervicalcancertodihydroartemisinininducedferritinophagydependentferroptosis